Gilead Sciences' Q4 2024 results, driven by HIV drug demand and Trodelvy growth, make it a compelling choice for long-term ...
Everything you need to know about The Handmaid’s Tale Season 6, including its Hulu release date, cast, plot, and more.
What happened to Emily in The Handmaid’s Tale? It’s a question that remains after Alexis Bledel’s exit, and whether she’ll be in Season 6.
Gilead Sciences has announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application ...
Gilead Sciences reported strong fourth-quarter earnings with significant growth in its HIV and oncology segments.
Shares of Gilead Sciences ( GILD -1.77%) were jumping 7.9% higher on Wednesday at 11:34 a.m. The solid gain came after the ...
Learn more about whether Gilead Sciences, Inc. or Insmed Incorporated is a better investment based on AAII's A+ Investor ...
Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...
8d
GlobalData on MSNGilead’s lenacapavir moves closer to FDA approval for HIV PrEP useLenacapavir is already approved under the name Sunlenca as an HIV treatment for patients resistant to other medication ...
We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...
David Furnish’s leadership at EJAF proves brands can do more than raise awareness —they can dismantle stigma and drive ...
Salesforce's outlook fell short of analysts’ expectations, sending shares lower in extended trading Wednesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results